Added antibody step improves the reliability of Alzheimer's blood tests
Researchers at University Medicine Halle have developed a new method that could improve the reliability of blood tests for Alzheimer's disease. Current commercial tests often rely on the protein biomarker p-tau217, whose levels can rise in the early stages of the disease. However, the biomarker levels can also be elevated in other conditions, potentially leading to false-positive results. In a…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
